Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on March 25, 2026

Mar. 25, 2026

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Indeterminate GlobeNewswire

Mar. 25, 2026

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Indeterminate GlobeNewswire

Mar. 25, 2026

Verano to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

Indeterminate GlobeNewswire

Mar. 25, 2026

NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset

Indeterminate GlobeNewswire

Mar. 25, 2026

C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

Indeterminate GlobeNewswire

Mar. 25, 2026

Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers

Indeterminate GlobeNewswire

Mar. 25, 2026

Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval

Indeterminate GlobeNewswire

Mar. 25, 2026

Picard Medical Reports Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 25, 2026

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Indeterminate GlobeNewswire

Mar. 25, 2026

Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Indeterminate GlobeNewswire

Mar. 25, 2026

Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

Indeterminate GlobeNewswire

Mar. 25, 2026

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Indeterminate GlobeNewswire

Mar. 25, 2026

ADMA Biologics Addresses Misleading Short-Seller Report

Indeterminate GlobeNewswire

Mar. 25, 2026

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

Indeterminate GlobeNewswire

Mar. 25, 2026

[Latest] Global Patient Mechanical Lift Handling Equipment Market Size/Share Worth USD 4.42 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Indeterminate GlobeNewswire

Mar. 25, 2026

Boehringer Ingelheim delivers on late-stage pipeline with two key launches, grows sales by 7.3%* in a successful 2025

Indeterminate GlobeNewswire

Mar. 25, 2026

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

Indeterminate GlobeNewswire